Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

A proposed biology- and biomarker-based algorithm for management of acute GvHD

Bone Marrow Transplantation volume 52, pages 337–340 (2017)Cite this article

Subjects

Herein, we attempt to integrate the new insights of diagnosis, risk stratification and potential novel therapies into the current standard of care in the hope of establishing a framework to be used in the design of future clinical trials to test these novel discoveries.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Kreisel W, Dahlberg M, Bertz H, Harder J, Potthoff K, Deibert P et al. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant 2012; 47: 430–438.

    Article  CAS  Google Scholar 

  2. Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Cashen AF et al. Peritransplant serum albumin decline predicts subsequent severe acute graft-versus-host disease after mucotoxic myeloablative conditioning. Biol Blood Marrow Transplant 2016; 22: 1137–1141.

    Article  Google Scholar 

  3. Hillen U, Häusermann P, Massi D, Janin A, Wolff D, Lawitschka A et al. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol 2015; 29: 948–954.

    Article  CAS  Google Scholar 

  4. Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002; 100: 3903–3907.

    Article  CAS  Google Scholar 

  5. Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F et al. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802. Biol Blood Marrow Transplant 2015; 21: 1029–1036.

    Article  CAS  Google Scholar 

  6. Ali AM, DiPersio JF, Schroeder MA . The role of biomarkers in the diagnosis and risk stratification of acute graft-versus-host disease: a systematic review. Biol Blood Marrow Transplant 2016; 22: 1552–1564.

    Article  CAS  Google Scholar 

  7. McDonald GB, Tabellini L, Storer BE, Lawler RL, Martin PJ, Hansen JA . Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment. Blood 2015; 126: 113–120.

    Article  CAS  Google Scholar 

  8. Bayraktar UD, Milton DR, Guindani M, Rondon G, Chen J, Al-Atrash G et al. Optimal threshold and time of absolute lymphocyte count assessment for outcome prediction after bone marrow transplantation. Biol Blood Marrow Transplant 2016; 22: 505–513.

    Article  Google Scholar 

  9. Rigoni L, Scroferneker ML, Pitombeira BS, Ottoni E, Paz A, Fischer G et al. Importance of early absolute lymphocyte count after allogeneic stem cell transplantation: a retrospective study. Transplant Proc 2015; 47: 511–516.

    Article  CAS  Google Scholar 

  10. Henden AS, Hill GR . Cytokines in graft-versus-host disease. J Immunol 2015; 194: 4604–1.

    Article  CAS  Google Scholar 

  11. MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A et al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant 2015; 21: 761–767.

    Article  Google Scholar 

  12. Hings IM, Filipovich AH, Miller WJ, Blazar BL, McGlave PB, Ramsay NK et al. Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation 1993; 56: 577–580.

    Article  CAS  Google Scholar 

  13. Baehr PH, Levine DS, Bouvier ME, Hockenbery DM, Gooley TA, Stern JG et al. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 1995; 60: 1231–1238.

    Article  CAS  Google Scholar 

  14. Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2014; 49: 966–971.

    Article  CAS  Google Scholar 

  15. Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 2011; 365: 430–438.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, Bone Marrow Transplantation and Leukemia Section, Washington University School of Medicine, St Louis, MO, USA

    A M Ali, J F DiPersio & M A Schroeder

Authors
  1. A M Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J F DiPersio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M A Schroeder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A M Ali.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, A., DiPersio, J. & Schroeder, M. A proposed biology- and biomarker-based algorithm for management of acute GvHD. Bone Marrow Transplant 52, 337–340 (2017). https://doi.org/10.1038/bmt.2016.289

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.289

This article is cited by

Search

Advanced search

Quick links